China National Chemical Engineering (601117) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Oct, 2025Executive summary
Achieved revenue of RMB 135.85 billion for the first nine months of 2025, up 1.26% year-over-year.
Net profit attributable to shareholders reached RMB 4.23 billion, a 10.28% increase year-over-year.
New contract value signed was RMB 254.56 billion, with RMB 230.91 billion domestic and RMB 53.65 billion overseas.
Financial highlights
Q3 revenue was RMB 45.42 billion, up 4.32% compared to the same quarter last year.
Q3 net profit attributable to shareholders was RMB 1.13 billion, up 13.21% year-over-year.
Total assets at quarter-end were RMB 242.60 billion, up 3.93% from year-end 2024.
Shareholders’ equity reached RMB 65.53 billion, up 5.22% from year-end 2024.
Operating cash flow for the first nine months was negative RMB 5.58 billion.
Key financial ratios and metrics
Basic and diluted EPS for the first nine months was RMB 0.69, up 9.52% year-over-year.
Weighted average ROE increased by 0.06 percentage points to 6.62% year-over-year.
Gross margin for the first nine months was approximately 8.8%.
Latest events from China National Chemical Engineering
- Net profit up 13.15% to ¥6.44B, with record new contracts and strong overseas growth.601117
H2 202525 Mar 2026 - Revenue and net profit rose over 4% year-over-year, driven by strong new contracts and overseas growth.601117
H2 202418 Dec 2025 - Net profit rose 9.26% year-over-year to ¥3.10 billion on stable revenue and higher margins.601117
H1 20255 Dec 2025 - Q3 net profit surged 28.57% year-over-year, but operating cash flow turned negative.601117
Q3 202413 Jun 2025 - Revenue and profit declined, but gross margin and new contracts improved in H1 2024.601117
H1 202413 Jun 2025 - Net profit surged 18.77% in Q1 2025 despite a slight revenue dip and negative cash flow.601117
Q1 20256 Jun 2025